We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




MRI-Guided Radiation Therapy Reduces Long-Term Side Effects in Prostate Cancer Patients

By MedImaging International staff writers
Posted on 19 Nov 2024
Print article
Image: Dr. Amar Kishan notes that MRI-guided approach enables the use of significantly narrower planning margins when delivering radiation (Photo courtesy of UCLA)
Image: Dr. Amar Kishan notes that MRI-guided approach enables the use of significantly narrower planning margins when delivering radiation (Photo courtesy of UCLA)

Stereotactic body radiotherapy (SBRT) is a standard treatment for localized prostate cancer. However, the side effects of this treatment can be severe and long-lasting, impacting a patient’s urinary, bowel, and sexual functions. To protect healthy tissue, imaging scans are used to plan radiation therapy, creating small margins around the tumor. Magnetic resonance imaging (MRI) guidance allows for more precise treatment, reducing the margins around the prostate, which means less exposure to surrounding healthy tissue. The primary goal in radiation oncology research is to optimize radiation delivery to the tumor while minimizing damage to surrounding structures. Previous studies have indicated that MRI guidance for aggressive margin-reduction (AMR) in SBRT for prostate cancer reduces acute toxicity, but the long-term benefits remained unclear. A two-year analysis has now confirmed that MRI-guided SBRT not only reduces acute treatment toxicity but also offers sustained benefits for patients' quality of life.

In a two-year follow-up study, researchers from the UCLA Health Jonsson Comprehensive Cancer Center (Los Angeles, CA, USA) discovered that MRI-guided SBRT significantly reduced long-term side effects and enhanced quality of life, particularly in terms of bowel and sexual health, compared to traditional CT-guided treatment. This study was a secondary analysis of the phase 3 MIRAGE clinical trial, which assessed the impact of MRI guidance in delivering high-precision radiation therapy for prostate cancer, as opposed to the standard CT-guided SBRT that requires larger treatment margins.

The results revealed that patients receiving MRI-guided SBRT experienced fewer urinary and bowel side effects. Specifically, 27% of MRI-guided patients reported moderate or severe urinary issues, such as incontinence and irritation, compared to 51% of those receiving CT guidance. Furthermore, gastrointestinal toxicity, including bowel problems, was observed in only 1.4% of MRI-guided patients, a significant reduction compared to 9.5% in the CT-guided group. MRI guidance also led to improved scores on quality-of-life assessments, particularly in bowel function and sexual health. These findings, published in European Urology, suggest a promising shift in prostate cancer treatment, highlighting the potential of MRI-guided radiation therapy to improve patient outcomes.

“This study adds strong evidence that the enhanced precision and accuracy afforded by MRI-guided SBRT leads to significantly fewer urinary, bowel, and sexual side effects for men receiving prostate SBRT,” noted Dr. Amar Kishan, executive vice chair of radiation oncology at the David Geffen School of Medicine at UCLA and first author of the study. “The MRI-guided approach, which includes real-time tracking of the prostate itself and the use of a built-in MRI to help deliver the radiation, allows us to use significantly narrower planning margins when delivering radiation, leading to less radiation to normal tissues. This in turn reduces the risk of enduring side effects that can impact a patient’s quality of life."

New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
X-ray Diagnostic System
FDX Visionary-A
Wall Fixtures
MRI SERIES
Radiology Software
DxWorks

Print article

Channels

Nuclear Medicine

view channel
Image: Example of AI analysis of PET/CT images (Photo courtesy of Academic Radiology; DOI: 10.1016/j.acra.2024.08.043)

AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer

Immunotherapy has significantly advanced the treatment of primary lung cancer, but it can sometimes lead to a severe side effect known as interstitial lung disease. This condition is characterized by lung... Read more

General/Advanced Imaging

view channel
Image: AI-enabled analysis of images meant to catch one disease can reveal others (Photo courtesy of 123RF)

AI Tool Offers Opportunistic Screening for Heart Disease Using Repurposed CT Scans

In the field of medical imaging, the term "opportunistic screening" refers to the repurposing of existing medical images by radiologists to diagnose illnesses beyond what the scan was originally meant to find.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.